Enlivex (ENLV) CFO discloses initial share and option holdings

Rhea-AI Filing Summary

Enlivex Ltd. Chief Financial Officer Shachar Shlosberger filed an initial statement of beneficial ownership, reporting direct holdings of 139,314 Ordinary Shares, par value NIS 0.40 per share. This Form 3 also lists multiple employee stock options to buy additional Ordinary Shares at preset exercise prices.

The disclosed options cover blocks of underlying shares such as 10,000 shares at an exercise price of $3.2100 per share expiring on February 15, 2034, and 7,500 shares at $5.3400 per share expiring on March 29, 2032. Additional option positions include smaller grants at exercise prices of $2.6900, $4.6800, $6.2200 and $10.1200, with expiration dates extending through December 31, 2033. The filing reflects existing holdings only and does not show new purchases or sales.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Shlosberger Shachar

(Last) (First) (Middle)

14 EINSTEIN STREET

(Street)

NESS ZIONA 7403618

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Enlivex Ltd. [ ENLV ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares, par value NIS 0.40 per share	139,314	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	05/01/2020	12/31/2033	Ordinary Shares, par value NIS 0.40 per share	1,936	$2.69	D
Employee Stock Option (right to buy)	12/12/2021	12/31/2033	Ordinary Shares, par value NIS 0.40 per share	1,452	$6.22	D
Employee Stock Option (right to buy)	03/07/2021	12/31/2033	Ordinary Shares, par value NIS 0.40 per share	1,452	$2.69	D
Employee Stock Option (right to buy)	03/30/2024	03/31/2030	Ordinary Shares, par value NIS 0.40 per share	5,000	$4.68	D
Employee Stock Option (right to buy)	12/10/2022	12/31/2033	Ordinary Shares, par value NIS 0.40 per share	1,452	$10.12	D
Employee Stock Option (right to buy)	11/24/2025	02/15/2034	Ordinary Shares, par value NIS 0.40 per share	10,000	$3.21	D
Employee Stock Option (right to buy)	11/24/2025	03/29/2032	Ordinary Shares, par value NIS 0.40 per share	7,500	$5.34	D

Explanation of Responses:

	/s/ Shachar Shlosberger	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Enlivex (ENLV) Form 3 filing by the CFO disclose?

The Form 3 shows Enlivex CFO Shachar Shlosberger’s existing equity stake. It reports 139,314 Ordinary Shares held directly and several employee stock option grants over additional Ordinary Shares with specified exercise prices and expiration dates, establishing his baseline ownership as an insider.

How many Enlivex (ENLV) Ordinary Shares does the CFO directly own?

The CFO directly owns 139,314 Ordinary Shares of Enlivex Ltd. These shares have a par value of NIS 0.40 per share and represent his current direct equity position, separate from his employee stock options disclosed in the same Form 3 filing.

What stock options are reported in Enlivex (ENLV) CFO Shachar Shlosberger’s Form 3?

The filing lists multiple employee stock options to buy Ordinary Shares. Examples include 10,000 underlying shares at a $3.2100 exercise price expiring February 15, 2034 and 7,500 underlying shares at $5.3400 expiring March 29, 2032, plus several smaller grants at other exercise prices.

Does the Enlivex (ENLV) CFO Form 3 indicate recent share purchases or sales?

The Form 3 presents the CFO’s existing holdings and option positions as of the reported date. All entries are categorized as holdings with unknown transaction codes, and the summarized data show no recorded buy or sell transactions in this disclosure.

What are the key expiration dates for Enlivex (ENLV) CFO stock options?

The disclosed option grants expire on several dates, including March 31, 2030, March 29, 2032, December 31, 2033, and February 15, 2034. Each option series has its own exercise price and number of underlying Ordinary Shares associated with these expiration dates.